CardiologyPhase IIEnrolling
HEART-RHYTHM Study
Atrial Fibrillation
Study Overview
An investigational study evaluating a novel antiarrhythmic agent for patients with paroxysmal atrial fibrillation. The study uses continuous cardiac monitoring to assess rhythm control efficacy.
Inclusion Criteria
- ✓Adults aged 40-75 years
- ✓Documented paroxysmal AF
- ✓At least 2 AF episodes in past 3 months
- ✓Currently on rate control medication
Exclusion Criteria
- ✗Permanent AF
- ✗Prior ablation procedure
- ✗Heart failure with reduced EF
- ✗QTc prolongation
Study Details
Phase
Phase II
Duration
24 weeks
Location
Main Facility
Compensation
Up to $550 for time and travel
Have questions? Contact us